Better preservation of early hematopoietic progenitor cells when human peripheral blood progenitor cells are cryopreserved with 5 percent dimethylsulfoxide instead of 10 percent dimethylsulfoxide-Reference-Cited by-同舟云学术

Better preservation of early hematopoietic progenitor cells when human peripheral blood progenitor cells are cryopreserved with 5 percent dimethylsulfoxide instead of 10 percent dimethylsulfoxide

Published:2004-04-26 Issue:5 Volume:44 Page:785-789
ISSN:0041-1132
Container-title:Transfusion
language:en
Short-container-title:

Author:

Abrahamsen Jenny Foss,Rusten Leiv,Bakken Anne M.,Bruserud Øystein

Publisher

Wiley

Subject

Hematology,Immunology,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1537-2995.2004.03336.x/fullpdf

Reference21 articles.

1. Collection, cryopre-servation and subsequent viability of haemopoietic stem cells intended for treatment of chronic granulocytic leukaemia in blast-cell transformation;Goldman;Br J Haematol,1978

2. Clinical toxicity of cryopreserved bone marrow graft infusion;Davis;Blood,1990

3. Adverse reactions in patients transfused with cryopreserved marrow;Stroncek;Transfusion,1991

4. Clinical toxicity of cryopreserved circulating progenitor cell infusion;Zambelli;Anticancer Res,1998

5. Autologous stem cell trans-plantation with stem cells preserved in the presence of 4.5 and 2.2% DMSO;Lakota;Bone Marrow Transplant,1996

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-Term Cryopreservation of Peripheral Blood Stem Cell Harvest Using Low Concentration (4.35%) Dimethyl Sulfoxide with Methyl Cellulose and Uncontrolled Rate Freezing at -80 °C: An Effective Option in Resource-Limited Settings;Transplantation and Cellular Therapy;2023-12

2. Loss of CD34+ Cells and Effect of the Number of Viable Cryopreserved CD34+ Cells in the Infused Blood Grafts on Hematologic Recovery, Progression-Free Survival and Overall Survival in NHL Patients After Autologous Stem Cell Transplantation;Clinical Lymphoma Myeloma and Leukemia;2023-11

3. Viability of mononuclear cells in leukocyte concentrates at the stages of their preparation, freezing, and thawing;Bulletin of Siberian Medicine;2023-07-08

4. Higher Age (≥60 Years) Increases the Risk for Adverse Events during Autologous Hematopoietic Stem Cell Transplantation;Cancers;2023-03-03

5. Impact of the number of cryopreserved CD34 ⁺ cells in the infused blood grafts on hematologic recovery and survival in myeloma patients after autologous stem cell transplantation: Experience from the GOA study;Journal of Clinical Apheresis;2022-10-14